Status:
UNKNOWN
The Identification of Novel Prognostic Markers in Melanoma
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Malignant Melanoma
Eligibility:
All Genders
Brief Summary
The purpose of this project is to analyze tumour tissue from a group of subjects with malignant melanoma, who have been treated at the Royal Marsden Hospital.
Detailed Description
Background - The Royal Marsden Hospital and the Institute of Cancer Research constitute the largest comprehensive cancer centre in Europe. In addition to an in-house drug development program, phase I ...
Eligibility Criteria
Inclusion
- Diagnosis of melanoma
- Adequate paraffin-embedded material available for analysis.
- Adequate clinical follow-up information
- Written informed consent where applicable
Exclusion
- Inadequate paraffin-embedded material available
- Inadequate clinical follow-up information.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01002560
Start Date
December 1 2008
End Date
December 1 2009
Last Update
October 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom, SM2 5PT